Associations

Comments to the Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than Jan. 1, 2023.

The Association for Accessible Medicines has released its 2022 U.S. Generic & Biosimilar Medicines Savings report highlighting the value of generic and biosimilar medicines.

NACDS is engaging in the White House Conference on Hunger, Nutrition, and Health with commitments and recommendations, as well as hosting a satellite event to extend its reach.

The EPA’s GreenChill program recognized Giant for reaching its annual refrigerant emissions reduction goal in 2021.

The event will take place Nov. 30 at the Sheraton New York Times Square in New York City.

The award honors individuals maintaining a career of exceptional service and contributions within the consumer healthcare products industry.

Important personnel changes you should know this week.

The Avalere analysis shows that generic drugs continue to be misplaced on higher formulary tiers, unfairly driving up costs for patients.